Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RAN binding protein 20 pseudogene (RANBP20P) is classified as a pseudogene—a genomic DNA sequence similar to a functional gene but generally considered noncoding and nonfunctional. Pseudogenes can be transcribed and occasionally may play subtle roles in the regulation of parental gene expression, most often by acting as decoys for miRNAs or by influencing chromatin status. However, there are no data to suggest that RANBP20P is a functional therapeutic target, nor are there established disease associations or known pharmacological activities for this entity.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RAN binding protein 20 pseudogene (RANBP20P).